新華百貨(600785.SH):上海寶銀3期賬户本次被處置公司股份1257.16萬股
格隆匯1月1日丨新華百貨(600785.SH)公佈,公司於近日收到上海寶銀創贏最具巴菲特潛力對沖基金3期清算小組(以下簡稱"清算小組")發來的郵件通知,清算小組於2023年12月29日通過大宗交易賣出公司股票6,666,600股和5,905,000股,共計12,571,600股。
根據清算小組的通知,上海寶銀3期賬户本次被處置公司股份12,571,600股,約佔公司總股份的5.57%。本次權益變動後,上海寶銀3期賬户持有公司股份為1,464,217股,約佔公司總股份的0.65%,上海寶銀合計持有新華百貨股份為7,425,760股,約佔公司總股份的3.29%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.